ArticleDiscover oncology2025

Targeting autophagy in platinum-sensitive relapsed ovarian cancer: randomized phase II trial of hydroxychloroquine with chemotherapy with biomarker correlation.

Luxitaa Goenka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.